BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//NephU - ECPv6.1.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:NephU
X-ORIGINAL-URL:https://nephu.org
X-WR-CALDESC:Events for NephU
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210901T120000
DTEND;TZID=America/New_York:20210901T130000
DTSTAMP:20240329T033502
CREATED:20210806T203802Z
LAST-MODIFIED:20210902T032845Z
UID:10000670-1630497600-1630501200@nephu.org
SUMMARY:Overview Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
DESCRIPTION:NephU Community Advisors\, Dr Neera Dahl\, Dr Arlene Chapman\, and Dr Frederic F. Rahbari Oskoui present an overview of autosomal dominant polycystic kidney disease (ADPKD) and answer common questions health care professionals have about ADPKD. \n\n\n\nDrs Neera Dahl\, Arlene Chapman\, and Frederic F. Rahbari Oskoui are paid consultants for Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC). \n\n\n\n You must be logged in to register for this event.\nPlease Log In or Join Now\n \n Join To View\n Already A Member? Login\n \n \n\n\n\n\n \n\n\n\n\nIf you would like to register for the 3:00 pm to 4:00 pm EDT broadcast or 9:00 pm to 10:00 pm EDT broadcast\, please click below: \n\n\n\n\nRegister For The 3:00 pm Broadcast \n\n\n\nRegister For The 9:00 pm Broadcast \n\n\n\n\n\n\n\nFeatured Speakers\n\n\n\n\n\n\n\n\n\nLocation\n\n\n\nOnline
URL:https://nephu.org/event/overview-of-autosomal-dominant-polycystic-kidney-disease-adpkd-08062021-1200pm-session/
LOCATION:TX
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://nephu.org/wp-content/uploads/2021/04/Woman-Typing-On-Computer.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210901T150000
DTEND;TZID=America/New_York:20210901T160000
DTSTAMP:20240329T033502
CREATED:20210806T204013Z
LAST-MODIFIED:20210902T032928Z
UID:10000672-1630508400-1630512000@nephu.org
SUMMARY:Overview Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
DESCRIPTION:NephU Community Advisors\, Dr Neera Dahl\, Dr Arlene Chapman\, and Dr Frederic F. Rahbari Oskoui present an overview of autosomal dominant polycystic kidney disease (ADPKD) and answer common questions health care professionals have about ADPKD. \n\n\n\nDrs Neera Dahl\, Arlene Chapman\, and Frederic F. Rahbari Oskoui are paid consultants for Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC). \n\n\n\n You must be logged in to register for this event.\nPlease Log In or Join Now\n \n Join To View\n Already A Member? Login\n \n \n\n\n\n\n\n\nFeatured Speakers\n\n\n\n\n\n\n\n\n\nLocation\n\n\n\nOnline
URL:https://nephu.org/event/overview-of-autosomal-dominant-polycystic-kidney-disease-adpkd-08062021-300pm-session/
LOCATION:TX
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://nephu.org/wp-content/uploads/2021/04/Woman-Typing-On-Computer.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210901T210000
DTEND;TZID=America/New_York:20210901T220000
DTSTAMP:20240329T033502
CREATED:20210806T204405Z
LAST-MODIFIED:20210902T032915Z
UID:10000674-1630530000-1630533600@nephu.org
SUMMARY:Overview Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
DESCRIPTION:NephU Community Advisors\, Dr Neera Dahl\, Dr Arlene Chapman\, and Dr Frederic F. Rahbari Oskoui present an overview of autosomal dominant polycystic kidney disease (ADPKD) and answer common questions health care professionals have about ADPKD. \n\n\n\nDrs Neera Dahl\, Arlene Chapman\, and Frederic F. Rahbari Oskoui are paid consultants for Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC). \n\n\n\n You must be logged in to register for this event.\nPlease Log In or Join Now\n \n Join To View\n Already A Member? Login\n \n \n\n\n\n\n\n\nFeatured Speakers\n\n\n\n\n\n\n\n\n\nLocation\n\n\n\nOnline
URL:https://nephu.org/event/overview-of-autosomal-dominant-polycystic-kidney-disease-adpkd-08062021-900pm-session/
LOCATION:TX
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://nephu.org/wp-content/uploads/2021/04/Woman-Typing-On-Computer.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210914T120000
DTEND;TZID=America/New_York:20210914T130000
DTSTAMP:20240329T033502
CREATED:20210807T023633Z
LAST-MODIFIED:20210807T024949Z
UID:10000676-1631620800-1631624400@nephu.org
SUMMARY:Major Depressive Disorder In Chronic Kidney Disease
DESCRIPTION:A joint virtual live event for NephU & PsychU members. \n\n\n\nIn this virtual live event\, Alf Carroll\, MS\, PA-C\, and Alyssa Peckham\, PharmD\, BCPP discuss the high prevalence of major depressive disorder (MDD) among patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). \n\n\n\nMajor depressive disorder affects more than 260 million people worldwide.1 The reported prevalence of depression in patients with chronic kidney disease ranges from 20-65%.2 This webinar provides an overview of both MDD and CKD and discusses their overlap of symptomology. \n\n\n\n1World Health Organization. Fact Sheet on Depression. (2012) https://www.who.int/health-topics/depression#tab=tab_12Teles F et al. Clinics (Sao Paulo). 2014 ;69(3):198-202. \n\n\n\nAlf Carroll and Dr Alyssa Peckham are employees of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC). \n\n\n\n You must be logged in to register for this event.\nPlease Log In or Join Now\n \n Join To View\n Already A Member? Login\n \n \n\n\n\n\n\n\nFeatured Speakers\n\n\n\n\n\n\n\nLocation\n\n\n\nOnline
URL:https://nephu.org/event/major-depressive-disorder-in-chronic-kidney-disease-09142021-1200pm-session/
LOCATION:TX
CATEGORIES:Virtual Live Event
ATTACH;FMTTYPE=image/jpeg:https://nephu.org/wp-content/uploads/2020/12/Laptop-Focus_resize-8-Quality.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210916T120000
DTEND;TZID=America/New_York:20210916T130000
DTSTAMP:20240329T033502
CREATED:20210817T201808Z
LAST-MODIFIED:20210918T060546Z
UID:10000679-1631793600-1631797200@nephu.org
SUMMARY:Polycystic Kidney Disease Research - Past\, Present & Future: Part I
DESCRIPTION:Polycystic Kidney Disease (PKD) is the most commonly inherited disease that can lead to kidney failure.1 Although first described over 500 years ago\, it hasn’t been until recently (roughly the past 40 years)\, that the field has made significant strides towards understanding the genetic characteristics and the pathophysiology of this disease.2 Scientists and clinicians have discovered the genes responsible\, delineated dominant and recessive forms\, characterized the high degree of variability in presentation\, and made remarkable advances in understanding which clinical\, genetic\, epigenetic\, or environmental factors may contribute to a patient’s risk of progressing towards kidney failure faster than other PKD patients. \n\n\n\nPlease join us as leading experts\, James Calvet\, PhD and Arlene Chapman\, MD\, take us on a journey of the past discoveries\, clinical advancements made\, and the present state of affairs in the PKD research field with the NephU webinar titled\, “Polycystic Kidney Disease Research – Past\, Present and Future: Part I.” \n\n\n\nChebib FT\, Torres VE. Am J Kidney Dis. 2016;67(5):792–810.Ong AC et al. Lancet. 2015;385(9981):1993-2002.\n\n\n\n*Drs Calvet and Chapman are paid consultants of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC). Drs Sundar and Hajarnis are employees of OPDC. \n\n\n\n You must be logged in to register for this event.\nPlease Log In or Join Now\n \n Join To View\n Already A Member? Login\n \n \n\n\n\n\n \n\n\n\n\nIf you would like to register for the 9:00 pm to 10:00 pm EDT broadcast\, please click below: \n\n\n\n\nRegister For The 9:00 pm Broadcast\n\n\n\n\n\n\n\nFeatured Speakers\n\n\n\n\n\n\n\n \n \n \n Shirin Sundar\, PhD\n Nephrology Senior Clinical & Scientific Liaison\n \n \n \n \n \n \n \n \n \n\n\n \n \n \n Sachin Hajarnis\, PhD\n Nephrology Senior Medical Science Liaison\n \n \n \n \n \nOtsuka Pharmaceutical Development & Commercialization\, Inc.*\n \n \n Sachin Hajarnis\, PhD is a Senior Medical Science Liaison at Otsuka Pharmaceuticals. Dr Hajarnis has a Bachelors and Masters in Life Sciences from University of Mumbai\, India. He obtained a PhD in Biochemistry and Molecular Biology from Colorado State University. Dr Hajarnis joined the University of Texas Southwestern Medical school in Dallas\, as a post-doctoral fellow in the department of Nephrology where he performed basic research on various aspects of Polycystic Kidney Disease (PKD). He continued his studies on the role of micro-RNAs in PKD as a Research Scientist for several years before joining his current position at Otsuka. \n\n \n \n\n\nLocation\n\n\n\nOnline
URL:https://nephu.org/event/polycystic-kidney-disease-research-past-present-future-part-i/
LOCATION:TX
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://nephu.org/wp-content/uploads/2020/12/Computer-over-skyscraper-600x400-80-Percent.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210916T210000
DTEND;TZID=America/New_York:20210916T220000
DTSTAMP:20240329T033502
CREATED:20210817T202017Z
LAST-MODIFIED:20210918T060613Z
UID:10000680-1631826000-1631829600@nephu.org
SUMMARY:Polycystic Kidney Disease Research - Past\, Present & Future: Part I
DESCRIPTION:Polycystic Kidney Disease (PKD) is the most commonly inherited disease that can lead to kidney failure.1 Although first described over 500 years ago\, it hasn’t been until recently (roughly the past 40 years)\, that the field has made significant strides towards understanding the genetic characteristics and the pathophysiology of this disease.2 Scientists and clinicians have discovered the genes responsible\, delineated dominant and recessive forms\, characterized the high degree of variability in presentation\, and made remarkable advances in understanding which clinical\, genetic\, epigenetic\, or environmental factors may contribute to a patient’s risk of progressing towards kidney failure faster than other PKD patients. \n\n\n\nPlease join us as leading experts\, James Calvet\, PhD and Arlene Chapman\, MD\, take us on a journey of the past discoveries\, clinical advancements made\, and the present state of affairs in the PKD research field with the NephU webinar titled\, “Polycystic Kidney Disease Research – Past\, Present and Future: Part I.” \n\n\n\nChebib FT\, Torres VE. Am J Kidney Dis. 2016;67(5):792–810.Ong AC et al. Lancet. 2015;385(9981):1993-2002.\n\n\n\n*Drs Calvet and Chapman are paid consultants of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC). Drs Sundar and Hajarnis are employees of OPDC. \n\n\n\n You must be logged in to register for this event.\nPlease Log In or Join Now\n \n Join To View\n Already A Member? Login\n \n \n\n\n\n\n\n\nFeatured Speakers\n\n\n\n\n\n\n\n \n \n \n Shirin Sundar\, PhD\n Nephrology Senior Clinical & Scientific Liaison\n \n \n \n \n \n \n \n \n \n\n\n \n \n \n Sachin Hajarnis\, PhD\n Nephrology Senior Medical Science Liaison\n \n \n \n \n \nOtsuka Pharmaceutical Development & Commercialization\, Inc.*\n \n \n Sachin Hajarnis\, PhD is a Senior Medical Science Liaison at Otsuka Pharmaceuticals. Dr Hajarnis has a Bachelors and Masters in Life Sciences from University of Mumbai\, India. He obtained a PhD in Biochemistry and Molecular Biology from Colorado State University. Dr Hajarnis joined the University of Texas Southwestern Medical school in Dallas\, as a post-doctoral fellow in the department of Nephrology where he performed basic research on various aspects of Polycystic Kidney Disease (PKD). He continued his studies on the role of micro-RNAs in PKD as a Research Scientist for several years before joining his current position at Otsuka. \n\n \n \n\n\nLocation\n\n\n\nOnline
URL:https://nephu.org/event/polycystic-kidney-disease-research-past-present-future-part-i-session-2-900-pm-et/
LOCATION:TX
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://nephu.org/wp-content/uploads/2020/12/Computer-over-skyscraper-600x400-80-Percent.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210921T120000
DTEND;TZID=America/New_York:20210921T130000
DTSTAMP:20240329T033502
CREATED:20210818T200811Z
LAST-MODIFIED:20210922T024531Z
UID:10000682-1632225600-1632229200@nephu.org
SUMMARY:Diet Management In Autosomal Dominant Polycystic Kidney Disease (ADPKD): Ketogenic Diet - Part 1
DESCRIPTION:In this Part 1 of a 3 Part series\, we will briefly describe the pathophysiology of Autosomal Dominant Polycystic Kidney Disease (ADPKD) including its cellular\, metabolic\, and systemic impact. Then\, we will discuss the nutritional/diet management strategies for ADPKD\, with an emphasis on using the Ketogenic Diet. We will set the stage for Part 2\, describing a Plant-Focused Ketogenic Diet Program for improved ADPKD outcomes. \n\n\n\n*Dr Richard (Rick) Lindquist is a paid consultant of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC). Dr Laura Frank is an employee of OPDC. \n\n\n\n You must be logged in to register for this event.\nPlease Log In or Join Now\n \n Join To View\n Already A Member? Login\n \n \n\n\n\n\n \n\n\n\n\nIf you would like to register for the 9:00 pm to 10:00 pm EDT broadcast\, please click below: \n\n\n\n\nRegister For The 9:00 pm Broadcast\n\n\n\n\n\n\n\nFeatured Speakers\n\n\n\n\n\n \n \n \n Laura Frank\, PhD\, MPH\, RDN\, CD\n Nephrology Clinical & Scientific Liaison\n \n \n \n \n \n \n \n \n \n\n\nLocation\n\n\n\nOnline
URL:https://nephu.org/event/diet-management-in-autosomal-dominant-polycystic-kidney-disease-adpkd-ketogenic-diet-part-1/
LOCATION:TX
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://nephu.org/wp-content/uploads/2021/05/Kidney-Food_resize.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210921T210000
DTEND;TZID=America/New_York:20210921T220000
DTSTAMP:20240329T033503
CREATED:20210818T200825Z
LAST-MODIFIED:20210922T024557Z
UID:10000683-1632258000-1632261600@nephu.org
SUMMARY:Diet Management In Autosomal Dominant Polycystic Kidney Disease (ADPKD): Ketogenic Diet - Part 1
DESCRIPTION:In this Part 1 of a 3 Part series\, we will briefly describe the pathophysiology of Autosomal Dominant Polycystic Kidney Disease (ADPKD) including its cellular\, metabolic\, and systemic impact. Then\, we will discuss the nutritional/diet management strategies for ADPKD\, with an emphasis on using the Ketogenic Diet. We will set the stage for Part 2\, describing a Plant-Focused Ketogenic Diet Program for improved ADPKD outcomes. \n\n\n\n*Dr Richard (Rick) Lindquist is a paid consultant of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC). Dr Laura Frank is an employee of OPDC. \n\n\n\n You must be logged in to register for this event.\nPlease Log In or Join Now\n \n Join To View\n Already A Member? Login\n \n \n\n\n\n\n\n\nFeatured Speakers\n\n\n\n\n\n \n \n \n Laura Frank\, PhD\, MPH\, RDN\, CD\n Nephrology Clinical & Scientific Liaison\n \n \n \n \n \n \n \n \n \n\n\nLocation\n\n\n\nOnline
URL:https://nephu.org/event/diet-management-in-autosomal-dominant-polycystic-kidney-disease-adpkd-ketogenic-diet-part-1-900-pm-eastern-session/
LOCATION:TX
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://nephu.org/wp-content/uploads/2021/05/Kidney-Food_resize.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210928T120000
DTEND;TZID=America/New_York:20210928T130000
DTSTAMP:20240329T033503
CREATED:20210903T061634Z
LAST-MODIFIED:20210903T071538Z
UID:10000684-1632830400-1632834000@nephu.org
SUMMARY:Racial Disparities In Autosomal Dominant Polycystic Kidney Disease
DESCRIPTION:Did you know that Black patients with autosomal dominant polycystic kidney disease (ADPKD) progress to kidney failure earlier than White patients?1\,2 Watch a rebroadcast of this virtual panel discussion\, led by nephrology experts\, where you can hear about the racial disparities that exist in autosomal dominant polycystic kidney disease (ADPKD)\, underrepresentation of Black Americans and other people of color in clinical trials\, and implicit bias that may impact the treatment of those with ADPKD. \n\n\n\nReferences \n\n\n\nYium J et al. J Am Soc Nephrol. 1994;4(9):1670–4.Murphy et al. BMC Nephrology (2019) 20:55.\n\n\n\n*Drs Neera Dahl\, and Loretta Jackson Brown are paid consultants of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC). Drs Charlotte Jones-Burton & Shirin Sundar are employees of OPDC. \n\n\n\nThe findings and conclusions in this presentation are those of the author and do not necessarily represent the views of the Centers for Disease Control and Prevention/the Agency for Toxic Substances and Disease Registry. \n\n\n\n You must be logged in to register for this event.\nPlease Log In or Join Now\n \n Join To View\n Already A Member? Login\n \n \n\n\n\n\n \n\n\n\n\nIf you would like to register for the 6:00 pm to 7:00 pm EDT broadcast or 9:00 pm to 10:00 pm EDT broadcast\, please click below: \n\n\n\n\nRegister For The 6:00 pm Broadcast \n\n\n\nRegister For The 9:00 pm Broadcast \n\n\n\n\n\n\n\nFeatured Speakers\n\n\n\n\n\n\n\n\n\n \n \n \n Shirin Sundar\, PhD\n Nephrology Senior Clinical & Scientific Liaison\n \n \n \n \n \n \n \n \n \n\n\nLocation\n\n\n\nOnline
URL:https://nephu.org/event/racial-disparities-in-autosomal-dominant-polycystic-kidney-disease-09282021-1200pm-session/
LOCATION:TX
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://nephu.org/wp-content/uploads/2020/10/Concerned-Man_resize.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210928T180000
DTEND;TZID=America/New_York:20210928T190000
DTSTAMP:20240329T033503
CREATED:20210903T062452Z
LAST-MODIFIED:20210903T071611Z
UID:10000685-1632852000-1632855600@nephu.org
SUMMARY:Racial Disparities In Autosomal Dominant Polycystic Kidney Disease
DESCRIPTION:Did you know that Black patients with autosomal dominant polycystic kidney disease (ADPKD) progress to kidney failure earlier than White patients?1\,2 Watch a rebroadcast of this virtual panel discussion\, led by nephrology experts\, where you can hear about the racial disparities that exist in autosomal dominant polycystic kidney disease (ADPKD)\, underrepresentation of Black Americans and other people of color in clinical trials\, and implicit bias that may impact the treatment of those with ADPKD. \n\n\n\nReferences \n\n\n\nYium J et al. J Am Soc Nephrol. 1994;4(9):1670–4.Murphy et al. BMC Nephrology (2019) 20:55.\n\n\n\n*Drs Neera Dahl\, and Loretta Jackson Brown are paid consultants of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC). Drs Charlotte Jones-Burton & Shirin Sundar are employees of OPDC. \n\n\n\nThe findings and conclusions in this presentation are those of the author and do not necessarily represent the views of the Centers for Disease Control and Prevention/the Agency for Toxic Substances and Disease Registry. \n\n\n\n You must be logged in to register for this event.\nPlease Log In or Join Now\n \n Join To View\n Already A Member? Login\n \n \n\n\n\n\n\n\nFeatured Speakers\n\n\n\n\n\n\n\n\n\n \n \n \n Shirin Sundar\, PhD\n Nephrology Senior Clinical & Scientific Liaison\n \n \n \n \n \n \n \n \n \n\n\nLocation\n\n\n\nOnline
URL:https://nephu.org/event/racial-disparities-in-autosomal-dominant-polycystic-kidney-disease-09282021-600pm-session/
LOCATION:TX
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://nephu.org/wp-content/uploads/2020/10/Concerned-Man_resize.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210928T210000
DTEND;TZID=America/New_York:20210928T220000
DTSTAMP:20240329T033503
CREATED:20210903T062726Z
LAST-MODIFIED:20210903T071620Z
UID:10000686-1632862800-1632866400@nephu.org
SUMMARY:Racial Disparities In Autosomal Dominant Polycystic Kidney Disease
DESCRIPTION:Did you know that Black patients with autosomal dominant polycystic kidney disease (ADPKD) progress to kidney failure earlier than White patients?1\,2 Watch a rebroadcast of this virtual panel discussion\, led by nephrology experts\, where you can hear about the racial disparities that exist in autosomal dominant polycystic kidney disease (ADPKD)\, underrepresentation of Black Americans and other people of color in clinical trials\, and implicit bias that may impact the treatment of those with ADPKD. \n\n\n\nReferences \n\n\n\nYium J et al. J Am Soc Nephrol. 1994;4(9):1670–4.Murphy et al. BMC Nephrology (2019) 20:55.\n\n\n\n*Drs Neera Dahl\, and Loretta Jackson Brown are paid consultants of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC). Drs Charlotte Jones-Burton & Shirin Sundar are employees of OPDC. \n\n\n\nThe findings and conclusions in this presentation are those of the author and do not necessarily represent the views of the Centers for Disease Control and Prevention/the Agency for Toxic Substances and Disease Registry. \n\n\n\n You must be logged in to register for this event.\nPlease Log In or Join Now\n \n Join To View\n Already A Member? Login\n \n \n\n\n\n\n\n\nFeatured Speakers\n\n\n\n\n\n\n\n\n\n \n \n \n Shirin Sundar\, PhD\n Nephrology Senior Clinical & Scientific Liaison\n \n \n \n \n \n \n \n \n \n\n\nLocation\n\n\n\nOnline
URL:https://nephu.org/event/racial-disparities-in-autosomal-dominant-polycystic-kidney-disease-09282021-900pm-session/
LOCATION:TX
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://nephu.org/wp-content/uploads/2020/10/Concerned-Man_resize.jpg
END:VEVENT
END:VCALENDAR